← Open Payments lookup

DAWN TAYLOR: Open Payments

NPI 1548826092 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$906 in 44 payments from 12 companies in 2025. Trend: 2023 $1,641 · 2024 $1,541 · 2025 $906

Food & beverage: $906
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.11$243
Novo Nordisk Inc8$168
Lilly USA, LLC7$148
AstraZeneca Pharmaceuticals LP5$100
Otsuka America Pharmaceutical, Inc.4$84
Exact Sciences Corporation2$38
Teva Pharmaceuticals USA, Inc.2$33
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Globus Medical, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20

Products named: Kerendia, MOUNJARO, AIRSUPRA, REXULTI, Ozempic, Wegovy, AUSTEDO XR, ZEPBOUND.

Industry payments across TX — which companies pay providers there.